OTC-BB:FOSUY

FOSUN FOR GOOD, CREATING IMPACT: Fosun International Issued its 2023 ESG Report and the Second Climate Information Disclosures Report

Retrieved on: 
Friday, April 26, 2024
Carbon, Carbon neutrality, Education, World Health Organization, NMPA, Malaria, HSI, Risk management, Culture, CSA, United Nations Global Compact, Climate, Disclosure, National Medical Products Administration, Sustainability, Create, Task force, Climate change, HKEX, Ecosystem, Health, SCLC, Biophysical environment, Temperature, AA, Cancer, Social, Hope, Policy, Paris Agreement, MSCI, Environment, Patient, Artesunate, ESG, The Bund Finance Center, Renewable energy

HONG KONG , April 26, 2024 /PRNewswire/ -- Fosun International Limited (HKEX stock code: 00656, "Fosun International"), together with its subsidiaries ("Fosun" or the "Group"), today issued the Environmental, Social and Governance (ESG) Report 2023 (the "ESG Report").

Key Points: 
  • HONG KONG , April 26, 2024 /PRNewswire/ -- Fosun International Limited (HKEX stock code: 00656, "Fosun International"), together with its subsidiaries ("Fosun" or the "Group"), today issued the Environmental, Social and Governance (ESG) Report 2023 (the "ESG Report").
  • Facing the increasingly severe challenges of global climate change, Fosun released its second Climate Information Disclosures Report with reference to the disclosure requirements of the Hong Kong Stock Exchange, the Task Force on Climate-Related Financial Disclosures ("TCFD") recommendations and IFRS S2 Climate-related Disclosures.
  • This year, the Group has actively pursued its carbon neutrality goal and issued the second Climate Information Disclosures Report.
  • For more information on Fosun's ESG, please refer to Fosun International's ESG Report 2023 posted on:
    The electronic copy of the 2023 Climate Information Disclosures Report is available on the Company's ESG webpage: ( https://en.fosun.com/esg/ )

Fosun's Subsidiary Fidelidade Announces Listing Plan of Private Health Service Company Luz Saúde

Retrieved on: 
Thursday, April 11, 2024
CMVM, Sale, Prospectus, Hospital, Bed, Accounting, Nursing, Patient, Growth, Euronext Lisbon

If realized, this operation will create better conditions for the continued expansion and growth of Luz Saúde in the health sector.

Key Points: 
  • If realized, this operation will create better conditions for the continued expansion and growth of Luz Saúde in the health sector.
  • Luz Saúde is recognized as a leading private health service provider in Portugal, noted for the quality and innovation of its approach.
  • After the public offering, Fidelidade intends to retain the majority of the share capital of Luz Saúde.
  • Fosun stated that Luz Saúde's listing plan marks an important milestone for both Luz Saúde and Fidelidade in the health sector, which will benefit the development of Fosun's Health segment and enhance Luz Saúde's corporate governance, and provide Luz Saúde an independent fundraising platform.

Fosun International: Total Revenue for 2023 Reached RMB198.2 billion, Industrial Operation Profit Increased by 20% YoY

Retrieved on: 
Tuesday, April 2, 2024
Gene, Artesunate, NMPA, Fosun International, Growth, Cell, Carcinoma, Patient, MSCI, FTG, Rehabilitation, Fosun Pharma, World Health Organization, National Medical Products Administration, Club Med, HKEX, Sustainability, Marketing, SCLC, HSI, AA

During the Reporting Period, the Group achieved a total revenue of RMB198.2 billion, representing a year-on-year increase of 8.6%.

Key Points: 
  • During the Reporting Period, the Group achieved a total revenue of RMB198.2 billion, representing a year-on-year increase of 8.6%.
  • Industrial operation profit reached RMB4.9 billion, representing a year-on-year increase of 20%.
  • Total revenue of the four core subsidiaries, namely Yuyuan, Fosun Pharma, Fosun Insurance Portugal and Fosun Tourism Group (FTG), was RMB142.69 billion, representing a year-on-year increase of 8%, contributing 72% of the revenue.
  • In 2023, Fosun's overseas revenue reached RMB89.2 billion, representing a year-on-year growth of 6% and accounting for 45% of the total revenue.

Fosun International: Total Revenue for 2023 Reached RMB198.2 billion, Industrial Operation Profit Increased by 20% YoY

Retrieved on: 
Tuesday, April 2, 2024
Gene, Artesunate, NMPA, Fosun International, Growth, Cell, Carcinoma, Patient, MSCI, FTG, Rehabilitation, Fosun Pharma, World Health Organization, National Medical Products Administration, Club Med, HKEX, Sustainability, Marketing, SCLC, HSI, AA

During the Reporting Period, the Group achieved a total revenue of RMB198.2 billion, representing a year-on-year increase of 8.6%.

Key Points: 
  • During the Reporting Period, the Group achieved a total revenue of RMB198.2 billion, representing a year-on-year increase of 8.6%.
  • Industrial operation profit reached RMB4.9 billion, representing a year-on-year increase of 20%.
  • Total revenue of the four core subsidiaries, namely Yuyuan, Fosun Pharma, Fosun Insurance Portugal and Fosun Tourism Group (FTG), was RMB142.69 billion, representing a year-on-year increase of 8%, contributing 72% of the revenue.
  • In 2023, Fosun's overseas revenue reached RMB89.2 billion, representing a year-on-year growth of 6% and accounting for 45% of the total revenue.

Fosun Management on 2023 Annual Results: Focusing on Core Industries with Established Advantages

Retrieved on: 
Friday, March 29, 2024
International, S&P, Research, Growth, Walking, CFO

Our core strategy revolves around directing our efforts towards enterprises where we have already established advantages.

Key Points: 
  • Our core strategy revolves around directing our efforts towards enterprises where we have already established advantages.
  • We used to "prospecting" and "exploration" across various industries and locations worldwide, and now we have evolved to 'deep mining' and 'developing good mines'.
  • Looking ahead, amidst all uncertainties, we must rely on our own stronger capabilities and greater certainty to navigate challenges."
  • Meanwhile, Fosun has continued to optimize its debt structure and strengthen liquidity management to prepare for the next phase of steady development.

Guo Guangchang: "Focus on building sustainable, predictable and enterprise with stable profit growth "

Retrieved on: 
Thursday, March 28, 2024
International, Fosun International, Research, Growth, Economic development, Walking, Environment

HONG KONG, March 28, 2024 /PRNewswire/ -- On March 28th, Fosun International Chairman Guo Guangchang said at the 2023 annual results conference, "We are even more clear that we must focus on building sustainable, predictable, and enterprise with stable profit growth.

Key Points: 
  • HONG KONG, March 28, 2024 /PRNewswire/ -- On March 28th, Fosun International Chairman Guo Guangchang said at the 2023 annual results conference, "We are even more clear that we must focus on building sustainable, predictable, and enterprise with stable profit growth.
  • Looking ahead, amidst all uncertainties, we must rely on our own stronger capabilities and greater certainty to navigate challenges."
  • In 2023, Fosun continued to implement core business-focused strategy, maintain steady development and improve its operating capabilities in advantageous industries.
  • Regarding technology innovation, Guo Guangchang stated, "We need to strengthen global business development and work together with partners.

Fosun International: Total Revenue for 2023 Reached RMB198.2 billion, Industrial Operation Profit Increased by 20% YoY

Retrieved on: 
Wednesday, March 27, 2024
Gene, Mining, PPT, Cell, RMB, Patient, Rehabilitation, TCFD, Marketing, World Health Organization, HSI, Artesunate, Carcinoma, MSCI, FTG, Telehealth, Lithium, National Medical Products Administration, HKEX, Sustainability, SCLC, AA, KOD, NMPA, Growth, Hope, Fosun Pharma, S&P, Task force, Club Med, Dragon

HONG KONG, March 27, 2024 /PRNewswire/ -- Fosun International Limited (HKEX stock code: 00656, "Fosun International"), together with its subsidiaries ("Fosun" or the "Group"), today announced its annual results for the year ended 31 December 2023 (the "Reporting Period").

Key Points: 
  • During the Reporting Period, the Group achieved a total revenue of RMB198.2 billion, representing a year-on-year increase of 8.6%.
  • Thanks to the Group's global business presence and continuous innovation, industrial operation profit reached RMB4.9 billion, representing a year-on-year increase of 20%.
  • Total revenue of the four core subsidiaries, namely Yuyuan, Fosun Pharma, Fosun Insurance Portugal and Fosun Tourism Group (FTG), was RMB142.69 billion, representing  a year-on-year increase of 8%, contributing 72% of the revenue.
  • In 2023, Fosun's overseas revenue reached RMB89.2 billion, representing a year-on-year growth of 6% and accounting for 45% of the total revenue.

Fosun Family Season Concludes with Over RMB10 Billion in Sales and Booming Family Consumption

Retrieved on: 
Monday, February 26, 2024
Yu Garden, Economic development, The Spring Festival, Classic, IPS, Yuyuan Tourist Mart, Tourism, Foot, Skin, Food, Club Med, Culture, Lunar New Year, Clothing, Health, City, History, Lantern Festival, Drink, Spring Festival, Dragon, Jewellery, Happiness, IP, Chinese New Year

This year's Fosun Family Season was held during the Chinese New Year period for the first time.

Key Points: 
  • This year's Fosun Family Season was held during the Chinese New Year period for the first time.
  • Highlights of this year's Fosun Family Season include total sales exceeding RMB10 billion, the overseas debut of Yuyuan Garden Lantern Festival, and the digital construction of Fosun Family Season.
  • With an emphasis on "stability" and even stronger emphasis on "progress" and "establishment", the highlights of this year's Fosun Family Season sent a more positive signal of high-quality development.
  • To date, this year's Yuyuan Garden Lantern Festival attracted more than 4 million visitors, and the sales performance during the holiday significantly improved.

Fosun International Included in S&P Global's Sustainability Yearbook 2024 and Recognized as Industry Mover

Retrieved on: 
Friday, February 9, 2024
Carbon, Sustainability, Education, Fosun International, Welfare, CSA, Culture, S&P Global, Health, ESG, Yearbook, Fertilizer

In its 20th edition now, the annual S&P Global Sustainability Yearbook aims to distinguish individual companies, within their industries, that have demonstrated strengths in corporate sustainability.

Key Points: 
  • In its 20th edition now, the annual S&P Global Sustainability Yearbook aims to distinguish individual companies, within their industries, that have demonstrated strengths in corporate sustainability.
  • Membership was highly competitive this year; of the over 9,400 companies in 62 industries assessed in the 2023 CSA, only 759 companies are included in the 2024 Sustainability Yearbook.
  • In 2023, Fosun International was successfully included in S&P Global's Sustainability Yearbook 2023 (China Edition) and was recognized as an "Industry Mover" for its commitment and progress in ESG initiatives.
  • Therefore, Fosun was recognized as an Industry Mover by S&P Global.

Fosun's S&P Global CSA ESG score jumped significantly, its MSCI ESG rating stood at AA for three consecutive years

Retrieved on: 
Tuesday, January 9, 2024
Global Compact, Water, Culture, Innovation management, CSA, HKEX, Sustainability, Sustainable development, Health, ESG, United, The Bund Finance Center, Education, Environmental policy, Business ethics, HSI, TCFD, Management, Task force, Social responsibility, Growth, Index, UN, The Business Council, Carbon, Safety, AA, United Nations, Renewable energy

Fosun International received an MSCI ESG rating of AA for three consecutive years and was the only conglomerate in Greater China with such rating.

Key Points: 
  • Fosun International received an MSCI ESG rating of AA for three consecutive years and was the only conglomerate in Greater China with such rating.
  • HONG KONG, Jan. 8, 2024 /PRNewswire/ -- Fosun International Limited ("Fosun International" or "Fosun", HKEX stock code: 00656) has recently received an update on its S&P Global Corporate Sustainability Assessment (CSA) score and MSCI ESG rating.
  • In addition, Fosun International received an MSCI ESG rating of AA for three consecutive years and was the only conglomerate in Greater China with such rating.
  • Fosun International received an MSCI ESG rating of AA for three consecutive years and was selected as a constituent of the MSCI CHINA ESG LEADERS 10-40 Index again, demonstrating the capital market's affirmation of Fosun's ESG management performance and long-term investment value.